These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8889281)

  • 61. Central neurotransmitter function and its behavioral correlates in man.
    Hanin I
    Environ Health Perspect; 1978 Oct; 26():135-41. PubMed ID: 31279
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Positron emission tomography imaging in dementia.
    Herholz K; Carter SF; Jones M
    Br J Radiol; 2007 Dec; 80 Spec No 2():S160-7. PubMed ID: 18445746
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Use of positron emission tomography in psychiatry].
    Degrell I; Berecz R; Glaub T; Lengyel Z; Egerházi A; Szakáll S; Trón L
    Orv Hetil; 2002 May; 143(21 Suppl 3):1311-4. PubMed ID: 12077925
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ratio-images calculated from interictal positron emission tomography and single-photon emission computed tomography for quantification of the uncoupling of brain metabolism and perfusion in epilepsy.
    Zubal IG; Avery RA; Stokking R; Studholme C; Corsi M; Dey H; Seibyl JP; Spencer SS
    Epilepsia; 2000 Dec; 41(12):1560-6. PubMed ID: 11114214
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Positron emission tomography studies of neurotransmitter systems.
    Sawle GV; Brooks DJ
    J Neurol; 1990 Dec; 237(8):451-6. PubMed ID: 1981574
    [No Abstract]   [Full Text] [Related]  

  • 66. Neuropharmacology and receptor studies in the elderly.
    Meltzer CC
    J Geriatr Psychiatry Neurol; 1999; 12(3):137-49. PubMed ID: 10593702
    [TBL] [Abstract][Full Text] [Related]  

  • 67. In vivo PET and SPECT receptor imaging: new technology and tactics for receptor measurement.
    Wong DF; Kuhar MJ
    Adv Exp Med Biol; 1988; 236():181-93. PubMed ID: 2907237
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Recent developments in PET scan imaging of neuroreceptors in schizophrenia.
    Sedvall G; Pauli S; Farde L; Karlsson P; Nyberg S; Nordström AL
    Isr J Psychiatry Relat Sci; 1995; 32(1):22-9. PubMed ID: 7622344
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Measuring the neuromodulatory effects of drugs in man with positron emission tomography.
    Friston KJ; Grasby PM; Bench CJ; Frith CD; Cowen PJ; Liddle PF; Frackowiak RS; Dolan R
    Neurosci Lett; 1992 Jul; 141(1):106-10. PubMed ID: 1354845
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Measurement of neurotransmitter receptors by positron emission tomography: focus on the opiate receptor.
    Frost JJ
    NIDA Res Monogr; 1986; 74():15-24. PubMed ID: 2827031
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis, and behavioral data.
    Chen YC; Galpern WR; Brownell AL; Matthews RT; Bogdanov M; Isacson O; Keltner JR; Beal MF; Rosen BR; Jenkins BG
    Magn Reson Med; 1997 Sep; 38(3):389-98. PubMed ID: 9339439
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Abnormalities of energy metabolism in Alzheimer's disease studied with PET.
    Heiss WD; Szelies B; Kessler J; Herholz K
    Ann N Y Acad Sci; 1991; 640():65-71. PubMed ID: 1776760
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Functional imaging of epileptic foci with PET and SPECT.
    Tyler JL; Starr CW
    J S C Med Assoc; 1992 May; 88(5):258-62. PubMed ID: 1351115
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Target-specific PET probes for neurodegenerative disorders related to dementia.
    Kadir A; Nordberg A
    J Nucl Med; 2010 Sep; 51(9):1418-30. PubMed ID: 20810758
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dynamic coupling of whole-brain neuronal and neurotransmitter systems.
    Kringelbach ML; Cruzat J; Cabral J; Knudsen GM; Carhart-Harris R; Whybrow PC; Logothetis NK; Deco G
    Proc Natl Acad Sci U S A; 2020 Apr; 117(17):9566-9576. PubMed ID: 32284420
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pharmacological implications for neuroreceptor imaging.
    Verhoeff NP
    Eur J Nucl Med; 1991; 18(7):482-502. PubMed ID: 1680690
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The study of neurotransmitter interactions using positron emission tomography and functional coupling.
    Schloesser R; Simkowitz P; Bartlett EJ; Wolkin A; Smith GS; Dewey SL; Brodie JD
    Clin Neuropharmacol; 1996 Oct; 19(5):371-89. PubMed ID: 8889281
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Detection of neurotransmitter interactions with PET and SPECT by pharmacological challenge paradigms].
    Schlösser R
    Nervenarzt; 2000 Jan; 71(1):9-18. PubMed ID: 10695027
    [TBL] [Abstract][Full Text] [Related]  

  • 80. In vivo imaging of neurotransmitter systems using radiolabeled receptor ligands.
    Kegeles LS; Mann JJ
    Neuropsychopharmacology; 1997 Nov; 17(5):293-307. PubMed ID: 9348545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.